| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $4.1M | -60.7% |
| SG&A Expense | $3.2M | +382.7% |
| Operating Income | -$7.3M | +34.2% |
| Pre-tax Income | -$7.3M | +34.2% |
| Income Tax | $2K | — |
| Net Income | -$7.3M | +34.2% |
| EPS (Basic) | -$0.27 | +99.3% |
| EPS (Diluted) | -$0.27 | +99.3% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | — |
| Current Assets | $4.5M | +3343.2% |
| Total Assets | $4.5M | -55.1% |
| Current Liabilities | $181K | -87.4% |
| Total Liabilities | $181K | -94.0% |
| Stockholders' Equity | $4.3M | +251.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | -1102.6% |
| Investing Cash Flow | $5.0M | +1916.6% |
| Financing Cash Flow | $12.8M | — |